Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Preemption Deadlocks Supreme Court; Congress Pushes To Resolve Issue

Executive Summary

Citing a crisis within FDA, members of Congress are demanding that the agency withdraw its proposed rule to limit when drug and device manufacturers can revise their product labeling without prior FDA approval

You may also be interested in...



GlaxoSmithKline Hires Former FDA Top Lawyer Dan Troy As General Counsel

Former FDA Chief Counsel Daniel Troy will once again be leading a team of lawyers with a drug regulatory focus

GlaxoSmithKline Hires Former FDA Top Lawyer Dan Troy As General Counsel

Former FDA Chief Counsel Daniel Troy will once again be leading a team of lawyers with a drug regulatory focus

Public Citizen Litigation Group: Industry’s Relentless Adversary

Public Citizen Litigation Group has had plenty to cheer about this year. It argued four cases before the U.S. Supreme Court, winning three of them. Its one loss was particularly disappointing, though

Related Content

UsernamePublicRestriction

Register

PS049381

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel